Evaluation of ticlopidine, a novel inhibitor of platelet aggregation, in heart transplant recipients.
INSERM U.63, Laboratory of Biochemistry, Hôpital Cardiologique, Lyon, France.
M
M
de Lorgeril
P
P
Boissonnat
G
G
Dureau
J
J
Guidollet
S
S
Renaud
D000328:Adult; D000368:Aged; D003324:Coronary Artery Disease / Q000517:prevention & control; D004341:Drug Evaluation; D005260:Female; D016027:Heart Transplantation / Q000473:pathology / Q000502:physiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010974:Platelet Aggregation / Q000187:drug effects; D013988:Ticlopidine / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use
D013988:Ticlopidine